Patients should avoid IGF-1 LR3 without medical clearance if they have blood sugar problems, diabetes risk, cancer history, abnormal growth concerns, cardiovascular disease, kidney or liver issues, active illness, pregnancy, breastfeeding, or current prescription medication use
The Case for PT-141 FDA approval is not a technicality
& Krhenbhl, S
The Wolverine Stack: Why Researchers Study BPC-157 and TB-500 Together The nickname Wolverine Stack refers to the combined use of BPC-157 and TB-500 in research protocols, borrowed from the Marvel character's fictional rapid-healing ability
For users with sensitive skin, rosacea, perioral dermatitis, or a history of retinoid intolerance, this difference is clinically meaningful and not merely cosmetic